2型大麻素受体信号调控急慢性移植物抗宿主病严重程度
本研究探讨2型大麻素受体(CB2R)在移植物抗宿主病(GVHD)中的作用。供者CD4+或CD8+ T细胞缺失CB2R或使用选择性CB2R拮抗剂加剧急性GVHD致死性,伴促炎CD8+ T细胞扩增。CB2R激动剂THC仅缓解T细胞介导的急性GVHD,JWH-133仅在硬化性慢性GVHD模型有效。
要点
- 供者T细胞CB2R缺失或拮抗加剧急性GVHD致死性
- THC缓解急性GVHD,JWH-133对慢性GVHD有效
- CB2R治疗靶向需考虑激动剂信号特性与致病效应细胞
核心结论
- CB2R在GVHD调控中起关键作用,有效治疗靶向取决于激动剂信号特性、受体选择性及致病免疫效应细胞组成。
研究设计与样本
- 使用CB2R缺失供者CD4+或CD8+ T细胞及选择性CB2R拮抗剂的急性GVHD模型。
- 使用新型CB2ReGFP报告小鼠观察急性GVHD中CB2R表达变化。
- 使用THC和JWH-133两种CB2R激动剂在急性GVHD和硬化性慢性GVHD模型中测试疗效。
- 体外检测THC和JWH-133诱导的arrestin招募和ERK磷酸化及对腺苷酸环化酶抑制的影响。
主要发现
- 供者CD4+或CD8+ T细胞缺失CB2R或给予选择性CB2R拮抗剂加剧急性GVHD致死性,伴促炎CD8+ T细胞扩增。
- 急性GVHD期间T细胞而非巨噬细胞上CB2R表达显著丢失。
- THC缓解致死性T细胞介导的急性GVHD,而JWH-133无效。
- JWH-133在巨噬细胞参与的硬化性慢性GVHD模型中有效,而THC无效。
- THC和JWH-133均通过CB2R诱导arrestin招募和ERK磷酸化,但THC对CB2R介导的腺苷酸环化酶抑制无影响。
临床怎么用
- CB2R激动剂治疗GVHD需根据急性或慢性GVHD及致病效应细胞类型选择不同激动剂。
- THC可能适用于T细胞介导的急性GVHD,JWH-133可能适用于巨噬细胞参与的慢性GVHD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Graft-versus-host disease (GVHD) pathophysiology is a complex interplay between cells that comprise the adaptive and innate arms of the immune system. Effective prophylactic strategies are therefore contingent upon approaches that address contributions from both immune cell compartments. In the current study, we examined the role of the type 2 cannabinoid receptor (CB2R), which is expressed on nearly all immune cells, and demonstrated that absence of the CB2R on donor CD4+ or CD8+ T cells or administration of a selective CB2R pharmacological antagonist exacerbated acute GVHD lethality. This was accompanied primarily by the expansion of proinflammatory CD8+ T cells, indicating that constitutive CB2R expression on T cells preferentially regulated CD8+ T-cell alloreactivity. Using a novel CB2ReGFP reporter mouse, we observed significant loss of CB2R expression on T cells, but not macrophages, during acute GVHD, indicative of differential alterations in receptor expression under inflammatory conditions. Therapeutic targeting of the CB2R with the agonists Δ9-tetrahydrocannabinol (THC) and JWH-133 revealed that only THC mitigated lethal T cell-mediated acute GVHD. Conversely, only JWH-133 was effective in a sclerodermatous chronic GVHD model where macrophages contributed to disease biology. In vitro, both THC and JWH-133 induced arrestin recruitment and extracellular regulated kinase phosphorylation via CB2R, but THC had no effect on CB2R-mediated inhibition of adenylyl cyclase. This study shows that the CB2R plays a critical role in the regulation of GVHD and suggests that effective therapeutic targeting is dependent upon agonist signaling characteristics and receptor selectivity in conjunction with the composition of pathogenic immune effector cells.
引用
- Yuan CY, Zhou V, Sauber G, et al. Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease. Blood. 2021. PMID: 33027805. doi:10.1182/blood.2020004871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。